Buscar
01/09/2024
Induction avelumab followed by chemoimmunotherapy and maintenance versus chemotherapy alone as first-line therapy in cis-ineligible metastatic urothelial carcinoma (INDUCOMAIN): a randomized phase II study
Rodriguez-Vida, A, Valderrama, BP, Castellano, D, Pinto, A, Mellado, B, Puente, J, Climent, MA, Domenech, M, Vazquez, F, Perez-Gracia, JL, Bonfill, T, Morales-Barrera, R, Gonzalez-Billalabeitia, E, Garcia-del-Muro, X, Maroto, P, Navarro-Gorro, N, Juanpere, N, Juan, O, Bellmunt, J. Induction avelumab followed by chemoimmunotherapy and maintenance versus chemotherapy alone as first-line therapy in cis-ineligible metastatic urothelial carcinoma (INDUCOMAIN): a randomized phase II study. ESMO Open. 2024; 9(9)DOI:10.1016/j.esmoop.2024.103690. PMID:39214051. IF:8.300(Q1/2D).
01/09/2024
ERCC1 and ERCC2 Polymorphisms Predict the Efficacy and Toxicity of Platinum-Based Chemotherapy in Small Cell Lung Cancer
Barba, A, López-Vilaró, L, Ferre, M, Majem, M, Martinez-Recio, S, Bell, O, Arranz, MJ, Salazar, J, Sullivan, I. ERCC1 and ERCC2 Polymorphisms Predict the Efficacy and Toxicity of Platinum-Based Chemotherapy in Small Cell Lung Cancer. Pharmaceutics. 2024; 16(9)DOI:10.3390/pharmaceutics16091121. PMID:39339159. IF:5.500(Q1/1D).
01/09/2024
Pancreatic adenocarcinoma associated with intraductal papillary mucinous neoplasm: a case series
Prat, A, Piñol, D, Espadaler, I, Campazas, I, Espinosa, I, Fusté, V, Szafranska, J, Fumagalli, C. Pancreatic adenocarcinoma associated with intraductal papillary mucinous neoplasm: a case series. VIRCHOWS ARCHIV. 2024; 485DOI:. PMID:. IF:3.100(Q2/3D).
01/09/2024
NKX2.2 expression in Ewing sarcoma: differences in sensitivity between pre-treatment biopsy and surgical specimen - a case series
Prat, A, Di Muro, MA, Acosta, SF, Vazquez, T, Rosell, SB, Orellana, R, Fumagalli, C. NKX2.2 expression in Ewing sarcoma: differences in sensitivity between pre-treatment biopsy and surgical specimen - a case series. VIRCHOWS ARCHIV. 2024; 485DOI:. PMID:. IF:3.100(Q2/3D).
01/09/2024
Prognostic impact of tumor location and gene expression profile in sporadic desmoid tumor
Carrillo-García, J, Hindi, N, Conceicao, M, Sala, MA, Ugalde, A, López-Pousa, A, Bagué, S, Sevilla, I, Vicioso, L, Ramos, R, Martínez-Trufero, J, Mateo, MCG, Cruz, J, Hernández-León, CN, Redondo, A, Mendiola, M, García, JM, Hernández, JE, Alvarez, R, Agra, C, de Juan-Ferré, A, Valverde, C, Cano, JM, de Sande, LM, Pérez-Fidalgo, JA, Lavernia, J, Marcilla, D, Gutiérrez, A, Moura, DS, Martín-Broto, J. Prognostic impact of tumor location and gene expression profile in sporadic desmoid tumor. EUROPEAN JOURNAL OF CANCER. 2024; 209DOI:10.1016/j.ejca.2024.114270. PMID:39142211. IF:7.100(Q1/2D).
01/09/2024
Voice Outcome After Carbon Dioxide Transoral Laser Microsurgery for Glottic Cancer According to the European Laryngological Society Classification of Cordectomy Types – A Systematic Review
Sjogren E., Hendriksma M., Piazza C., Hartl D.M., Suarez C., Cohen O., de Bree R., Quer M., Poorten V.V., Rodrigo J.P., Civantos F., Genden E., Kowalski L.P., Makitie A., Shaha A., Takes R.P., Sanabria A., Guntinas-Lichius O., Rinaldo A., Ferlito A.. Voice Outcome After Carbon Dioxide Transoral Laser Microsurgery for Glottic Cancer According to the European Laryngological Society Classification of Cordectomy Types – A Systematic Review. JOURNAL OF VOICE. 2024; 38(5)DOI:10.1016/j.jvoice.2022.03.003. PMID:35422356. IF:2.400(Q1/1D).
01/09/2024
HPV-associated multiphenotypic sinonasal carcinoma. Tumour with indolent behaviour? A case-control study
Ballús, DP, López, L, Bagué, S, Gonzalez, A, Holgado, A, Gras, JR, Szafranska, J. HPV-associated multiphenotypic sinonasal carcinoma. Tumour with indolent behaviour? A case-control study. VIRCHOWS ARCHIV. 2024; 485DOI:. PMID:. IF:3.100(Q2/3D).
01/09/2024
Sinonasal hamarthomas: a rare entity with a challenging diagnosis - how an accurate diagnosis impacts clinical and therapeutic management
Vilaró, LL, Prat, A, Piñol, D, Catasús, L, Rosell, SB, Casasayas, M, Cabrerizo, JRG, Szafranska, J. Sinonasal hamarthomas: a rare entity with a challenging diagnosis - how an accurate diagnosis impacts clinical and therapeutic management. VIRCHOWS ARCHIV. 2024; 485DOI:. PMID:. IF:3.100(Q2/3D).